Skip to main content
. Author manuscript; available in PMC: 2013 Jan 30.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2009 Aug 6;29(11):1757–1763. doi: 10.1161/ATVBAHA.109.191775

Figure 6. IL-1β-induced CXCL5 and CXCL6 expression is mediated by B1R activation and enhanced under low LSS conditions.

Figure 6

HUVEC were subjected to low LSS for 12h and treated with IL-1β (10ng/mL) for 4h in the absence or presence of the B1R antagonist SSR240612 (1μM, 15 min prior to IL-1β application). (A) CXCL5 or (B) CXCL6 mRNA expression was measured levels normalized to GAPDH. Data are mean ± SEM for n=6, ** for P<0.01.